Figure 7 | Scientific Reports

Figure 7

From: A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma

Figure 7

Independent prognostic validation of OS nomogram for ESCC patients. (A, B) Univariate and Multivariate analysis for all cohorts. (C, D) Nomogram and nomogram to predict 1-, 3-, and 5-year OS rates of ESCC patients. (E) ROC curves for clinical characteristics and nomogram. OS overall survival, ESCC esophageal squamous cell carcinoma, ROC receiver operator characteristic.

Back to article page